Eli Lilly CEO Dave Ricks on Thursday said the drugmaker can help "respond" to national security concerns around cheaper essential medicines as pharmaceutical-specific tariffs loom.
The Trump administration has opened a Section 232 investigation into how importing certain drugs into the…